Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies
- PMID: 20103777
- PMCID: PMC2909749
- DOI: 10.1161/CIRCHEARTFAILURE.109.899526
Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies
Abstract
Background: Little is known about the effects of hypokalemia on outcomes in patients with chronic heart failure (HF) and chronic kidney disease.
Methods and results: Of the 7788 patients with chronic HF in the Digitalis Investigation Group trial, 2793 had chronic kidney disease, defined as estimated glomerular filtration rate <60 mL/min per 1.73 m(2). Of these, 527 had hypokalemia (serum potassium <4 mEq/L; mild) and 2266 had normokalemia (4 to 4.9 mEq/L). Propensity scores for hypokalemia were used to assemble a balanced cohort of 522 pairs of patients with hypokalemia and normokalemia. All-cause mortality occurred in 48% and 36% of patients with hypokalemia and normokalemia, respectively, during 57 months of follow-up (matched hazard ratio when hypokalemia was compared with normokalemia, 1.56; 95% CI, 1.25 to 1.95; P<0.0001). Matched hazard ratios (95% CIs) for cardiovascular and HF mortalities and all-cause, cardiovascular, and HF hospitalizations were 1.65 (1.29 to 2.11; P<0.0001), 1.82 (1.28 to 2.57; P<0.0001), 1.16 (1.00 to 1.35; P=0.036), 1.27 (1.08 to 1.50; P=0.004), and 1.29 (1.05 to 1.58; P=0.014), respectively. Among 453 pairs of balanced patients with HF and chronic kidney disease, all-cause mortality occurred in 47% and 38% of patients with mild hypokalemia (3.5 to 3.9 mEq/L) and normokalemia, respectively (matched hazard ratio, 1.31; 95% CI, 1.03 to 1.66; P=0.027). Among 169 pairs of balanced patients with estimated glomerular filtration rate <45 mL/min per 1.73 m(2), all-cause mortality occurred in 57% and 47% of patients with hypokalemia (<4 mEq/L; mild) and normokalemia, respectively (matched hazard ratio, 1.53; 95% CI, 1.07 to 2.19; P=0.020).
Conclusions: In patients with HF and chronic kidney disease, hypokalemia (serum potassium <4 mEq/L) is common and associated with increased mortality and hospitalization.
Conflict of interest statement
No authors have any conflicts of interest in relation to this manuscript.
Figures



Similar articles
-
Mild hyperkalemia and outcomes in chronic heart failure: a propensity matched study.Int J Cardiol. 2010 Oct 29;144(3):383-8. doi: 10.1016/j.ijcard.2009.04.041. Epub 2009 Jun 5. Int J Cardiol. 2010. PMID: 19500863 Free PMC article.
-
Potassium supplementation and long-term outcomes in chronic peritoneal dialysis patients with end-stage renal disease: a propensity score matching study.Ren Fail. 2016 Nov;38(10):1594-1600. doi: 10.3109/0886022X.2015.1128237. Epub 2016 Oct 24. Ren Fail. 2016. PMID: 27771983
-
Oral potassium supplement use and outcomes in chronic heart failure: a propensity-matched study.Int J Cardiol. 2010 May 28;141(2):167-74. doi: 10.1016/j.ijcard.2008.11.195. Epub 2009 Jan 9. Int J Cardiol. 2010. PMID: 19135741 Free PMC article.
-
Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes.Am J Nephrol. 2017;46(3):213-221. doi: 10.1159/000479802. Epub 2017 Sep 2. Am J Nephrol. 2017. PMID: 28866674 Free PMC article.
-
Association of potassium disorders with the mode of death and etiology in patients with chronic heart failure: the INCOR-HF study.Sci Rep. 2024 Dec 4;14(1):30167. doi: 10.1038/s41598-024-74928-x. Sci Rep. 2024. PMID: 39627200 Free PMC article.
Cited by
-
Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.Am J Nephrol. 2015;41(6):456-63. doi: 10.1159/000437151. Epub 2015 Jul 25. Am J Nephrol. 2015. PMID: 26228532 Free PMC article.
-
Hyperkalemia in Heart Failure with Reduced Ejection Fraction: Implications and Management.Heart Fail Rev. 2025 Aug 22. doi: 10.1007/s10741-025-10549-4. Online ahead of print. Heart Fail Rev. 2025. PMID: 40841869 Review.
-
Prevalence and Factors Associated with Potassium Abnormalities Among Outpatients with Heart Failure Taking Diuretics in a Tertiary Referral Hospital in Tanzania.East Afr Health Res J. 2024;8(1):142-147. doi: 10.24248/eahrj.v8i1.759. Epub 2024 Mar 28. East Afr Health Res J. 2024. PMID: 39234354 Free PMC article.
-
Impact of Abnormal Potassium on Arrhythmia Risk During Pediatric Digoxin Therapy.Pediatr Cardiol. 2024 Apr;45(4):901-908. doi: 10.1007/s00246-022-03051-3. Epub 2022 Nov 20. Pediatr Cardiol. 2024. PMID: 36403164 Review.
-
Immediate and Delayed Response of Simulated Human Atrial Myocytes to Clinically-Relevant Hypokalemia.Front Physiol. 2021 May 26;12:651162. doi: 10.3389/fphys.2021.651162. eCollection 2021. Front Physiol. 2021. PMID: 34122128 Free PMC article.
References
-
- The National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–266. - PubMed
-
- The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336:525–533. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous